Delcath Systems (DCTH) Change in Account Payables (2020 - 2021)

Delcath Systems' (DCTH) quarterly Change in Account Payables came in at -$548000.0 in Q4 2021, up 59.82% year-on-year from -$342877.1 in Q4 2020, and down 1342.11% quarter-over-quarter from -$38000.0 in Q3 2021.

Delcath Systems (DCTH) Change in Account Payables (2020 - 2021) Analysis & Trends

Delcath Systems' Change in Account Payables history runs 2 years deep, the most recent figure standing at -$548000.0 for Q4 2021.

  • On a quarterly basis, Change in Account Payables rose 59.82% year-over-year to -$548000.0 in Q4 2021; TTM through Dec 2021 was -$2.6 million, a N/A change from a year earlier, with the FY2021 full-year figure at -$1.1 million, up 74.16% from the prior year.
  • Change in Account Payables fell to -$548000.0 in Q4 2021 per DCTH's latest filing, from -$38000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at -$38000.0 in Q3 2021 and bottomed at -$1.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -198.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 221.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Delcath Systems 16,569.19 -89.28 Mn 21.26 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -548,000.00
Dec 31, 2021 -548,000.00
Sep 30, 2021 -38,000.00
Sep 30, 2021 -38,000.00
Dec 31, 2020 -1.36 Mn
Dec 31, 2020 -1.36 Mn
Sep 30, 2020 -673,000.00
Sep 30, 2020 -673,000.00